TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | -5.89%440.82B | -5.17%296.06B | -2.19%149.73B | -4.11%617.23B | -3.05%468.43B | -1.73%312.19B | -4.02%153.08B | 6.32%643.67B | 7.82%483.18B | 7.29%317.67B |
-Interest income | 0.16%938.14B | 1.66%627.01B | 4.70%314.69B | 6.56%1.25T | 7.90%936.59B | 9.10%616.75B | 7.86%300.57B | 10.71%1.17T | 10.81%867.99B | 9.57%565.32B |
-Interest expense | -6.23%-497.32B | -8.66%-330.96B | -11.85%-164.96B | -19.59%-630.13B | -21.66%-468.17B | -22.98%-304.57B | -23.75%-147.49B | -16.59%-526.9B | -14.80%-384.81B | -12.64%-247.65B |
Net service income | -10.29%85.14B | -11.20%62.7B | -8.69%39.28B | -0.29%115.75B | 0.04%94.91B | 0.50%70.6B | 4.73%43.02B | -4.45%116.09B | -1.80%94.87B | 1.17%70.25B |
-Service income | -10.35%94.25B | -11.29%68.73B | -9.97%42.21B | -0.71%129.91B | -0.97%105.13B | 0.43%77.47B | 2.86%46.88B | -5.63%130.83B | -2.51%106.16B | -0.56%77.14B |
-Service charge | 10.92%-9.1B | 12.25%-6.03B | 24.18%-2.93B | 3.97%-14.16B | 9.43%-10.22B | 0.28%-6.87B | 14.25%-3.86B | 14.00%-14.75B | 8.07%-11.28B | 15.25%-6.89B |
Dividend income | 7.68%5.48B | -14.49%3.05B | -43.27%278M | -6.89%5.71B | -6.49%5.09B | 1.68%3.57B | -17.79%490M | 3.61%6.14B | 8.34%5.44B | -4.05%3.51B |
Net transaction income | -3.70%4.67B | 6.29%4B | 12.87%2.08B | 56.53%5.69B | 35.01%4.84B | 65.61%3.77B | 35.37%1.84B | -53.53%3.63B | -16.34%3.59B | -20.77%2.27B |
Securities and investments income | 1,473.24%6.83B | 733.95%4.52B | 32.47%2.66B | 97.55%-222M | 92.79%-497M | 113.40%542M | 134.73%2.01B | -186.32%-9.06B | -186.21%-6.89B | -318.35%-4.05B |
Special items of operating revenue | 539.59%9.42B | 279.58%4.5B | 147.53%1.26B | 149.54%1.46B | 44.26%-2.14B | -1,219.20%-2.51B | -85.51%507M | -121.75%-2.95B | -136.69%-3.84B | -96.80%224M |
Operating revenue | -3.20%552.35B | -3.43%374.83B | -2.82%195.28B | -1.57%745.62B | -0.99%570.63B | -0.44%388.16B | 0.36%200.95B | -0.94%757.51B | 0.66%576.34B | 2.35%389.88B |
Operating expenses - before deducting impairment | 0.79%-145.21B | 1.67%-94.39B | 0.65%-44.79B | -0.07%-220.15B | -3.42%-146.37B | -2.07%-95.99B | -1.90%-45.08B | -0.37%-219.99B | -2.94%-141.53B | -6.67%-94.04B |
Operating profit before deducting impairment | -4.04%407.13B | -4.01%280.44B | -3.45%150.5B | -2.24%525.46B | -2.43%424.26B | -1.24%292.17B | -0.08%155.87B | -1.47%537.52B | -0.06%434.81B | 1.06%295.84B |
Impairment and provisions | 11.95%-109.54B | 8.11%-87.64B | 6.56%-48.15B | 11.47%-137.24B | 12.12%-124.41B | 7.75%-95.37B | 0.55%-51.53B | 8.12%-155.01B | 1.17%-141.58B | 4.73%-103.38B |
-Impairment losses of other assets | 11.95%-109.54B | 8.11%-87.64B | 6.56%-48.15B | 11.47%-137.24B | 12.12%-124.41B | 7.75%-95.37B | 0.55%-51.53B | 8.12%-155.01B | 1.17%-141.58B | 4.73%-103.38B |
Operating profit after deducting impairment | -0.75%297.59B | -2.03%192.81B | -1.91%102.35B | 1.50%388.23B | 2.25%299.84B | 2.25%196.8B | 0.15%104.34B | 1.51%382.51B | 0.49%293.24B | 4.47%192.47B |
Operating profit | -0.75%297.59B | -2.03%192.81B | -1.91%102.35B | 1.50%388.23B | 2.25%299.84B | 2.25%196.8B | 0.15%104.34B | 1.51%382.51B | 0.49%293.24B | 4.47%192.47B |
Share of profits of associates | -94.87%44M | -55.60%206M | -112.40%-45M | -3.60%1.15B | 10.71%858M | 11.00%464M | 271.23%363M | -25.51%1.19B | -22.34%775M | 83.33%418M |
Earning before tax | -1.02%297.64B | -2.16%193.01B | -2.29%102.31B | 1.48%389.38B | 2.28%300.7B | 2.27%197.26B | 0.71%104.71B | 1.40%383.7B | 0.41%294.01B | 4.57%192.88B |
Tax | 10.46%-40.53B | 6.66%-27.97B | 1.02%-15.4B | 3.26%-56.92B | 2.39%-45.26B | 2.22%-29.97B | 3.67%-15.56B | 21.01%-58.84B | 22.23%-46.37B | -0.97%-30.65B |
After-tax profit from continuing operations | 0.65%257.11B | -1.35%165.04B | -2.51%86.91B | 2.34%332.46B | 3.15%255.44B | 3.12%167.3B | 1.51%89.15B | 6.89%324.86B | 6.20%247.64B | 5.27%162.23B |
Earning After tax | 0.65%257.11B | -1.35%165.04B | -2.51%86.91B | 2.34%332.46B | 3.15%255.44B | 3.12%167.3B | 1.51%89.15B | 6.89%324.86B | 6.20%247.64B | 5.27%162.23B |
Minority profit | 9,642.86%1.34B | 1,555.10%713M | -77.72%90M | -241.91%-193M | 87.04%-14M | -114.63%-49M | 143.77%404M | -90.39%136M | -110.59%-108M | -58.44%335M |
Profits attributable to shareholders | 0.13%255.78B | -1.80%164.33B | -2.17%86.82B | 2.44%332.65B | 3.11%255.45B | 3.36%167.34B | 0.00%88.74B | 7.34%324.73B | 6.72%247.75B | 5.61%161.9B |
Basic earnings per share | -0.98%1.01 | -1.49%0.66 | 0.00%0.35 | 2.34%1.31 | 3.03%1.02 | 3.08%0.67 | 0.00%0.35 | 7.56%1.28 | 6.45%0.99 | 6.56%0.65 |
Diluted earnings per share | -0.98%1.01 | -1.49%0.66 | 0.00%0.35 | 2.34%1.31 | 3.03%1.02 | 3.08%0.67 | 0.00%0.35 | 7.56%1.28 | 6.45%0.99 | 6.56%0.65 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.